# Phreesia, Inc. > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Phreesia, Inc.). ## Overview Phreesia, Inc. provides a SaaS-based patient intake and payment platform for healthcare organizations in the United States. Its products help medical practices and other healthcare services clients register patients, collect payments, and deliver patient communications, while its life sciences offerings support patient engagement and health-related marketing campaigns. ## Products & services • Patient intake and registration software • Patient payment processing platform • Healthcare client onboarding and support services • Life sciences patient engagement campaigns • Direct communications for healthcare and advocacy groups - **Healthcare services platform** (60%) — SaaS tools for patient intake, registration, scheduling-related workflows, and practice operations. - **Payment processing** (25%) — Patient payment facilitation and related transaction fees tied to healthcare visits. - **Life sciences communications** (15%) — Campaigns and direct communications used by life sciences customers to engage patients. - Patient intake and registration software - Patient payment processing platform - Healthcare client onboarding and support services - Life sciences patient engagement campaigns - Direct communications for healthcare and advocacy groups ## Customers Phreesia sells primarily to healthcare services organizations such as medical practices and other outpatient providers across the U.S. It also serves life sciences companies, healthcare advertising agencies, government entities, and advocacy groups that use its platform for patient outreach and education. Customer relationships are typically sold through direct sales, with annual auto-renewing contracts common in healthcare services. - **Healthcare services clients** (primary) — Medical practices and other healthcare providers that buy intake, registration, and payment workflow tools to streamline patient visits. - **Life sciences customers** (secondary) — Pharmaceutical and other life sciences organizations that buy patient communications and campaign services to activate and educate patients. - **Healthcare advertising agencies** (secondary) — Agencies that purchase or manage patient-facing campaign services on behalf of healthcare and life sciences clients. - **Government and advocacy organizations** (emerging) — Public-sector and advocacy buyers that use Phreesia for targeted health communications and outreach. - Medical practices and healthcare services organizations - Life sciences companies running patient engagement campaigns - Healthcare advertising agencies buying campaign delivery - Government entities and advocacy groups for outreach programs - Multi-location providers seeking workflow and payment automation ## Geography Phreesia focuses substantially all of its sales efforts within the United States, and substantially all of its historical revenue has come from the U.S. The company also has employees in non-U.S. jurisdictions such as Canada and India, which affects operating support and compliance exposure, but the commercial footprint remains overwhelmingly domestic. - **United States** (100%) — Company states substantially all historical revenue has come from the U.S. - Substantially all revenue comes from the United States - Sales efforts are concentrated in the U.S. healthcare market - Non-U.S. employees are based in Canada and India - Domestic focus reduces foreign revenue diversification - U.S. healthcare regulation shapes product design and sales ## Strategy Phreesia’s strategy centers on expanding adoption of its healthcare workflow platform, increasing use of add-on solutions, and deepening relationships with existing clients through onboarding, training, and support. It also uses direct sales and marketing to grow life sciences campaigns and to retain customers through annual renewals and land-and-expand selling. - **Land-and-expand in healthcare services** (medium-term) — Broader product adoption raises account value and supports retention. - **Improve implementation speed and client experience** (short-term) — Faster go-live and smoother onboarding help win and retain accounts. - **Grow life sciences communications revenue** (medium-term) — Campaign-based offerings broaden the customer base beyond providers. - Expand healthcare client adoption through direct sales - Increase add-on solution penetration within existing accounts - Use implementation support to speed client go-live - Retain customers through training and optimization programs - Grow life sciences campaigns through annual reselling ## Risks Phreesia operates in a competitive healthcare technology market where it must integrate with EHR and practice management systems and keep pace with changing client needs and AI-enabled products. Its business also depends on third-party hardware suppliers and contract manufacturers, while revenue concentration in the U.S. ties performance to domestic healthcare regulation, customer budgets, and adoption cycles. - **Competitive pressure from integrated healthcare software vendors** [high] — Customers may prefer bundled EHR/PM solutions or lower-cost alternatives. - **Supplier concentration for PhreesiaPad and Arrivals Kiosks** [high] — A sole or limited supplier base can disrupt hardware availability and client deployments. - **Regulatory and compliance change in U.S. healthcare** [medium] — Product workflows and patient communications must adapt to changing rules. - **Customer renewal and sales-cycle risk** [medium] — Annual auto-renewing contracts and competitive sales processes can delay growth. - **Technology obsolescence and AI-driven competition** [medium] — Rapid product innovation could weaken differentiation if Phreesia does not keep pace. - Competition from EHR and practice management vendors - Dependence on third-party hardware suppliers and manufacturers - U.S. healthcare regulation and evolving compliance requirements - Client adoption and renewal risk in annual contracts - Technology change, including AI-enabled competing products ## Accounting Revenue recognition is central because Phreesia earns from subscriptions, related services, payment processing fees, and campaign-based life sciences work, each of which may be recognized differently depending on performance obligations. Capitalized internal-use software, business combination fair values, stock-based compensation, and doubtful accounts are also important because they can materially affect reported earnings and asset values. - **Revenue recognition** — Affects reported revenue mix and quarterly comparability - **Capitalized internal-use software** — Can shift operating costs between periods - **Business combination valuation** — Can create future impairment risk and affect amortization - **Allowance for doubtful accounts** — Impacts net revenue and working capital - **Stock-based compensation** — Can materially affect reported profitability - Revenue recognition across subscriptions, services, and campaigns - Payment processing fees depend on patient payment volume - Capitalized internal-use software affects operating expense timing - Business combinations require fair value estimates - Stock-based compensation and doubtful accounts require judgment --- *Last updated: 2026-04-29T04:48:43.584226+00:00*